Targeting Metabolism for Cancer Therapy
Cited by (929)
Items 101–200 of 929
- The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targetsJulie E. Burns, Carolyn D. Hurst, Margaret A. Knowles, Roger M. Phillips, Simon J. Allison · 2021 · Cancer Science
- Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathwayMona Hoseini Soflaee, Rushendhiran Kesavan, Umakant Sahu, Alpaslan Tasdogan, Elodie Villa, Zied Djabari, Feng Cai, Diem Hong Tran, Hieu Vu, Eunus Sheemul Ali et al. · 2022 · Nature Communications
- Adoptive T reg therapy with metabolic intervention via perforated microneedles ameliorates psoriasis syndromeWentao Zhang, Yingxin Chen, Zhengjie Zhao, Hanqi Zheng, Shenqiang Wang, Ziyan Liao, Tao Sheng, Sheng Zhao, Wenhui Hou, Xinmin Yu et al. · 2023 · Science Advances
- The emerging role of targeting cancer metabolism for cancer therapyPegah Farhadi, Reza Yarani, Sadat Dokaneheifard, Kamran Mansouri · 2020 · Tumor Biology
- Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer ProgressionQingxiang Lin, Yuan He, Xue Wang, Yong Zhang, Meichun Hu, Weikai Guo, Yundong He, Tao Zhang, Li Lai, Zhenliang Sun et al. · 2020 · Advanced Science
- PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancerHuan Deng, Yamei Chen, Peijing Li, Qingqing Hang, Peng Zhang, Ying Jin, Ming Chen · 2022 · Cancer Pathogenesis and Therapy
- Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell linesTia Tidwell, Gro Vatne Røsland, Karl Johan Tronstad, Kjetil Søreide, Hanne Røland Hagland · 2022 · Cancer & Metabolism
- Metabolic determinants of tumour initiationJulia S. Brunner, Lydia W.S. Finley · 2022 · Nature Reviews Endocrinology
- Targeting Metabolic Reprogramming in Acute Myeloid LeukemiaIsabel Castro, Belém Sampaio‐Marques, Paula Ludovico · 2019 · Cells
- HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor HeterogeneityDimitris Karagiannis, Theodoros N Rampias · 2021 · Cancers
- Mass spectrometry imaging-based metabolomics to visualize the spatially resolved reprogramming of carnitine metabolism in breast cancerChenglong Sun, Fukai Wang, Yang Zhang, Jinqian Yu, Xiao Wang · 2020 · Theranostics
- Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD–Driven Acute Myeloid LeukemiaStefan Bjelosevic, Emily Gruber, Andrea Newbold, Carolyn Shembrey, Jennifer R. Devlin, Simon J. Hogg, Lev M. Kats, Izabela Todorovski, Zheng Fan, Thomas C. Abrehart et al. · 2021 · Cancer Discovery
- A second Warburg‐like effect in cancer metabolism: The metabolic shift of glutamine‐derived nitrogenManabu Kodama, Keiichi I. Nakayama · 2020 · BioEssays
- Inhibition of Cancer Cell Migration and Glycolysis by Terahertz Wave Modulation via Altered Chromatin AccessibilityLan Sun, Yangmei Li, Yun Yu, Peiliang Wang, Shengquan Zhu, Kaijie Wu, Yan Liu, Ruixing Wang, Li Min, Chao Chang · 2022 · Research
- Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancerMans Broekgaarden, Sriram R. Anbil, Anne‐Laure Bulin, Girgis Obaid, Zhiming Mai, Yan Baglo, Imran Rizvi, Tayyaba G. Hasan · 2019 · Biomaterials
- Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cellsValentí Gómez, Thomas R. Eykyn, Rami Mustapha, Fabian Flores‐Borja, Victoria H. Male, Paul R. Barber, Antonia Patsialou, Ryan J. Green, Fani Panagaki, Chun W. Li et al. · 2020 · Science Signaling
- Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancerAlba Luengo, Keene L. Abbott, Shawn M. Davidson, Aaron M. Hosios, Brandon Faubert, Sze Ham Chan, Elizaveta Freinkman, Lauren G. Zacharias, Thomas P. Mathews, Clary B. Clish et al. · 2019 · Nature Communications
- Metabolic reprogramming and disease progression in cancer patientsLaura Torresano, Cristina Nuevo‐Tapioles, Fulvio Santacatterina, Jose Manuel Cuezva · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate CancerTakuma Uo, Cynthia C.T. Sprenger, Stephen R. Plymate · 2020 · Frontiers in Oncology
- Deregulated transcription factors in cancer cell metabolisms and reprogrammingRajni Kant, Rajesh Manne, Mohammad Anas, Vasudevarao Penugurti, Tingjin Chen, Bo‐Syong Pan, Che-Chia Hsu, Hui‐Kuan Lin · 2022 · Seminars in Cancer Biology
- Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinomaMaria Victoria Recouvreux, Shea F. Grenier, Yijuan Zhang, Edgar Esparza, Guillem Lambies, Cheska Marie Galapate, Swetha Maganti, Karen Duong‐Polk, Deepika Bhullar, Razia F. Naeem et al. · 2023 · Nature Cancer
- Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic ImplicationsAndrea Comba, Syed Mohd Faisal, Maria Luisa Varela, Todd Charles Hollon, Wajd N. Al‐Holou, Yoshie Umemura, Felipe Javier Núñez, Sébastien Motsch, Maria Graciela Castro, Pedro Ricardo Lowenstein · 2021 · Frontiers in Oncology
- Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?Laura A. Sena, Samuel Ray Denmeade · 2021 · Cancer Research
- Emerging roles of nucleotide metabolism in cancer development: progress and prospectJingsong Ma, Mengya Zhong, Yubo Xiong, Zhi Gao, Zhengxin Wu, Yu Liu, Xuehui Hong · 2021 · Aging
- Inhibition of Δ24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolutionAndreas Körner, Enchen Zhou, Christoph Müller, Yassene Mohammed, Sandra Herceg, Franz Bracher, Patrick C.N. Rensen, Yanan Wang, Valbona Mirakaj, Martin A. Giera · 2019 · Proceedings of the National Academy of Sciences
- Trained immunity as a novel therapeutic strategyVera P. Mourits, Jac CHM Wijkmans, Leo A. B. Joosten, Mihai Gheorghe Netea · 2018 · Current Opinion in Pharmacology
- The Role of the Microbiome in the Etiopathogenesis of Colon CancerGeniver El Tekle, Natalia Andreeva, Wendy S. Garrett · 2024 · Annual Review of Physiology
- Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic OpportunitiesCarina Neitzel, Philipp Demuth, Simon Wittmann, Jörg Fahrer · 2020 · Cancers
- The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancerYuuki Ohara, Paloma Valenzuela, S. Perwez Hussain · 2022 · Trends in cancer
- RNA helicase DDX21 mediates nucleotide stress responses in neural crest and melanoma cellsCristina Santoriello, Audrey Sporrij, Song P. Yang et al. · 2020 · Nature Cell Biology
- An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinomaChenlei Wen, Ke Huang, Lu-Lu Jiang, Xiongxiong Lu, Yuting Dai, Min-Min Shi, Xiao-Mei Tang, Qingbing Wang, Xiaodan Zhang, Peng‐Hui Wang et al. · 2019 · Proceedings of the National Academy of Sciences
- Inhibition of the mitochondrial protein Opa1 curtails breast cancer growthMargherita Zamberlan, Amandine Boeckx, Florian Muller, Federica Vinelli, Olivier Ek, Caterina Vianello, Emeline Coart, Keitaro Shibata, Aurélie Christian, Francesca Grespi et al. · 2022 · Journal of Experimental & Clinical Cancer Research
- Recent advances in cancer metabolism: a technological perspectiveYun Pyo Kang, Nathan P. Ward, Gina M. DeNicola · 2018 · Experimental & Molecular Medicine
- Deregulation of SPOP in CancerHui Zhang, Xiaofeng Jin, Haojie Huang · 2022 · Cancer Research
- A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cellsChiara Ghezzi, Alicia Wong, Bao Ying Chen, Bernard Ribalet, Robert D. Damoiseaux, Peter M. Clark · 2019 · Nature Communications
- Control of cell metabolism by the epidermal growth factor receptorLaura A. Orofiamma, Dafne Vural, Costin N. Antonescu · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progressionLei Zhou, Ken HO Yu, Tin Lok Wong, Zhao Zhang, Chun Ho Chan, Jane Ho Chun Loong, Noélia Che, Hua Yu, Kel Vin Tan, Man Tong et al. · 2021 · Gut
- Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant TransformationTashbib Khan, Mitchell A. Sullivan, Jennifer H. Gunter, Thomas Kryza, Nicholas Lyons, Yaowu He, John David Hooper · 2020 · Frontiers in Oncology
- The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumorsHamidreza Zalpoor, Fatemeh Aziziyan, Mahsa Liaghat, Maryam Bakhtiyari, Abdullatif Akbari, Mohsen Nabi‐Afjadi, Razieh Forghaniesfidvajani, Nima Rezaei · 2022 · Cell Communication and Signaling
- Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug–Loaded NanoformulationsKhaled S. Allemailem, Ahmad Almatroudi, Mohammed A. Alsahli, Aseel Aljaghwani, Asmaa M. El-Kady, Arshad Husain Rahmani, Amjad Ali Khan · 2021 · International Journal of Nanomedicine
- Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cellsChien‐Liang Liu, Yi‐Chiung Hsu, Jie-Jen Lee, Ming‐Jen Chen, Chi‐Hsin Lin, Shih‐Yuan Huang, Shih‐Ping Cheng · 2019 · Molecular and Cellular Endocrinology
- The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer GrowthXi Liu, Yun Lu, Zibo Chen, Xiuxia Liu, Weiguo Hu, Lin Zheng, Yulong Chen, Jonathan M. Kurie, Mi Shi, Lisa Maria Mustachio et al. · 2020 · Molecular Cancer Research
- APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancerPu-Hyeon Cha, Jeongha Hwang, Dong-Kyu Kwak, Eunjin Koh, Kyung‐Sup Kim, Kang‐Yell Choi · 2020 · British Journal of Cancer
- Cancer metabolism and intervention therapyHuakan Zhao, Yongsheng Li · 2021 · Molecular Biomedicine
- NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyondDaria Capece, Daniela Verzella, Barbara Di Francesco, Edoardo Alesse, Guido Franzoso, Francesca Zazzeroni · 2019 · Seminars in Cell and Developmental Biology
- Metabolic Reprogramming as a Driver of Fibroblast Activation in PulmonaryFibrosisRachel Para, Freddy Romero, Gautam George, Ross S. Summer · 2019 · The American Journal of the Medical Sciences
- Inter-organelle cross-talk supports acetyl-coenzyme A homeostasis and lipogenesis under metabolic stressRamya S. Kuna, Avi Kumar, Héctor Gálvez, Karl A. Wessendorf-Rodriguez, Courtney R. Green, Grace H. McGregor, Thekla Cordes, Reuben J. Shaw, Robert U Svensson, Christian M. Metallo · 2023 · Science Advances
- NK Cell Metabolism and TGFβ – Implications for ImmunotherapyKaren Slattery, Clair M. Gardiner · 2019 · Frontiers in Immunology
- Linking Metabolic Reprogramming, Plasticity and Tumor ProgressionShuvalov, Oleg, Daks, Alexandra, Fedorova, Olga, Petukhov, Alexey, Barlev, Nickolai · 2021 · Cancers
- Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemiaLucille Stuani, Marie Sabatier, Jean‐Emmanuel Sarry · 2019 · BMC Biology
- Metabolism and immunity in breast cancerDeyu Zhang, Xiaojie Xu, Qinong Ye · 2020 · Frontiers of Medicine
- Endogenous toxic metabolites and implications in cancer therapyNamgyu Lee, Meghan E. Spears, Anne E. Carlisle, Dohoon Kim · 2020 · Oncogene
- LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerRamona Rudalska, Jule Harbig, Marteinn Thor Snaebjornsson, Sabrina Klotz, Stefan Zwirner, Liudmyla Taranets, Florian Heinzmann, Thales Kronenberger, Michael Förster, Wei Cui et al. · 2021 · Nature Cancer
- A systematic flux analysis approach to identify metabolic vulnerabilities in human breast cancer cell linesSheree D. Martin, Sean L. McGee · 2019 · Cancer & Metabolism
- The bidirectional relationship between metabolism and cell cycle controlFrances F. Diehl, Kiera M. Sapp, Matthew G. Vander Heiden · 2023 · Trends in Cell Biology
- A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade gliomaKeren Porper, Yael Shpatz, Л. Л. Плоткин, Ronit Goldman Pechthold, Alisa Talianski, Colin Eamon Champ, Orit Furman, Ariel Shimoni-Sebag, Zvi Symon, Uri Amit et al. · 2021 · Journal of Neuro-Oncology
- Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural MesotheliomaPeter Wojciech Szlosarek, Ben Creelan, Thomas Sarkodie, Luke Nolan, Paul D. Taylor, Olga M. Olevsky, Federica Grosso, Diego Luigi Cortinovis, Meenali M. Chitnis, Amy Roy et al. · 2024 · JAMA Oncology
- Recent advances in metabolism and toxicity of tyrosine kinase inhibitorsZhao, Qi, Wu, Zhanxuan E., Li, Bin, Li, Fei · 2022 · Pharmacology & Therapeutics
- MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic CancerQiangsheng Hu, Yi Qin, Shunrong Ji, Xiuhui Shi, Weixing Dai, Guixiong Fan, Shuo Li, Wenyan Xu, Wensheng Liu, Mengqi Liu et al. · 2021 · Cancer Research
- Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an updateGiuseppe Tiziano Lucarelli, Davide Loizzo, Matteo Ferro, Monica Rutigliano, Mihai Dorin Vartolomei, Francesco Cantiello, Carlo Buonerba, Giuseppe Di Lorenzo, Daniela Terracciano, Ottavio DE COBELLI et al. · 2019 · Expert Review of Molecular Diagnostics
- Pharmacological properties and mechanism insights of Moroccan anticancer medicinal plants: What are the next steps?Abdelhakim Bouyahya, Omar Belmehdi, Abdelaziz Benjouad, Rabii Ameziane El Hassani, Saaïd Amzazi, Nadia Dakka, Youssef Bakri · 2020 · Industrial Crops and Products
- Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal AdenocarcinomaVikrant Rai, Swati Agrawal · 2020 · International Journal of Molecular Sciences
- Identification of purine biosynthesis as an NADH-sensing pathway to mediate energy stressRonghui Yang, Chuanzhen Yang, Lingdi Ma, Yiliang Zhao, Zihao Guo, Jing Niu, Qiaoyun Chu, Yingmin Ma, Binghui Li · 2022 · Nature Communications
- Antimetabolic Effects of Polyphenols in Breast Cancer Cells: Focus on Glucose Uptake and MetabolismElisa Keating, Fátima Martel · 2018 · Frontiers in Nutrition
- The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolismEmmanuel Benichou, Bolaji Seffou, Selin Topçu, Ophélie Renoult, Véronique Lenoir, Julien Planchais, Caroline Bonner, Catherine Postic, Carina Prip‐Buus, Claire Pecqueur et al. · 2024 · Nature Communications
- Serine Metabolism Controls Dental Pulp Stem Cell Aging by Regulating the DNA Methylation of p16Ruili Yang, He Huang, C.S. Han, Shengjie Cui, Yan-Heng Zhou, Yanyan Zhou · 2020 · Journal of Dental Research
- Phenotypic plasticity during metastatic colonizationCharly Jehanno, Milica Vulin, Veronica Richina, Federica Richina, Mohamed Bentires‐Alj · 2022 · Trends in Cell Biology
- Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolismLei Dou, Enting Lu, Dongli Tian, Fangmei Li, Lei Deng, Yi Zhang · 2023 · Journal of Translational Internal Medicine
- Pan-cancer analysis of the metabolic reaction networkFrancesco Gatto, Raphaël Ferreira, Jens Nielsen · 2019 · Metabolic Engineering
- Metabolomics and lipidomics strategies in modern drug discovery and developmentGiuseppe Astarita, Rachel S. Kelly, Jessica Ann Lasky-Su · 2023 · Drug Discovery Today
- Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozinDavid J. Papadopoli, Oro Uchenunu, Ranveer Palia, Nabila Chekkal, Laura Hulea, Ivan Topisirović, Michaël Pollak, Julie St‐Pierre · 2021 · Neoplasia
- Oxygen as a Master Regulator of Human Pluripotent Stem Cell Function and MetabolismKinga Nit, Małgorzata Tyszka‐Czochara, Sylwia Bobis‐Wozowicz · 2021 · Journal of Personalized Medicine
- HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinomaJason C. Fleming, Jeongmin Woo, Karwan A. Moutasim, Massimiliano Mellone, Steven J. Frampton, Abbie Mead, Waseem Ahmed, Oliver Wood, Hollie Robinson, Matthew J. Ward et al. · 2019 · British Journal of Cancer
- Evaluation of Riboflavin Transporters as Targets for Drug Delivery and TheranosticsLisa Bartmann, David Schumacher, Saskia Freifrau von Stillfried, Marieke Sternkopf, Setareh Alampour‐Rajabi, Marc A. M. J. van Zandvoort, Fabian M. Kiessling, Zhuojun Wu · 2019 · Frontiers in Pharmacology
- Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as targetShaohua Ma, Chorlada Paiboonrungruan, Tiansheng Yan, Kevin P. Williams, Michael B. Major, Xiaoxin Luke Chen · 2018 · Annals of the New York Academy of Sciences
- Resveratrol, Curcumin and Piperine Alter Human Glyoxalase 1 in MCF-7 Breast Cancer CellsBetina Schmidt, Christian Ferreira, Carlos Luan Alves Passos, Jerson Lima Silva, Eliane Fialho · 2020 · International Journal of Molecular Sciences
- Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphomaRichard A. Noble, Huw D. Thomas, Yan Zhao, Lili Herendi, Rachel Howarth, Ilaria Dragoni, Hector C. Keun, Christopher P. Vellano, Joseph R. Marszalek, Stephen R. Wedge · 2022 · British Journal of Cancer
- Metabolic Reprogramming in Cancer: Implications for Immunosuppressive MicroenvironmentDurre Aden, Niti Sureka, Samreen Zaheer, Jai Kumar Chaurasia, Sufian Zaheer · 2024 · Immunology
- Targeting Cell Metabolism as Cancer TherapyNatalie Y.L. Ngoi, Jie Qing Eu, Jayshree L. Hirpara, Lingzhi Wang, Joline S.J. Lim, Soo Chin Lee, Yaw‐Chyn Lim, Shazib Pervaiz, Boon Cher Goh, Andrea Li Ann Wong · 2019 · Antioxidants and Redox Signaling
- Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidationJae‐Seon Lee, Seung Hwa Kim, Soohyun Lee, Joon Hee Kang, Seon-Hyeong Lee, Jae‐Ho Cheong, Soo‐Youl Kim · 2019 · Scientific Reports
- Understanding the Warburg Effect in CancerZhaoqi Li, Muhammad Bin Munim, Daniel A. Sharygin, Brooke J. Bevis, Matthew G. Vander Heiden · 2024 · Cold Spring Harbor Perspectives in Medicine
- CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicityYing Yu Liang, Smaranda Bacanu, Lekshmy Sreekumar, Anderson Daniel Ramos, Lingyun Dai, Martin Michaelis, Jindrich Jr. Cinatl, Takahiro Seki, Yihai Cao, Cynthia R. Coffill et al. · 2021 · Cell chemical biology
- Oxidative Stress and Cancer Development: Are Noncoding RNAs the Missing Links?Leonard Clinton D’Souza, Shruti Mishra, Anirban Chakraborty, Anusmita Shekher, Anurag Sharma, Subash C. Gupta · 2019 · Antioxidants and Redox Signaling
- Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma ProgressionYong Chun Chong, Tan Boon Toh, Zhiling Chan, Quy Xiao Xuan Lin, Dexter Kai Hao Thng, Lissa Hooi, Zhaobing Ding, Timothy Wai Ho Shuen, Han Chong Toh, Yock Young Dan et al. · 2020 · Hepatology Communications
- Emerging metabolomic tools to study cancer metastasisLuiza Martins Nascentes Melo, Nicholas P. Lesner, Marie Sabatier, Jessalyn M. Ubellacker, Alpaslan Tasdogan · 2022 · Trends in cancer
- The role of branched chain amino acids metabolic disorders in tumorigenesis and progressionJingtong Wang, Wei Wang, Feng Zhu, Qiuhong Duan · 2022 · Biomedicine & Pharmacotherapy
- Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasisNicole Kiweler, Catherine Delbrouck, Vitaly Igorevich Pozdeev, Laura Neises, Leticia Soriano‐Baguet, Kim Eiden, Feng Xian, Mohaned Benzarti, Lara Haase, Eric Koncina et al. · 2022 · Nature Communications
- KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challengesChangyun Li, Wanhe Wang, Chung‐Hang Leung, Guan‐Jun Yang, Jiong Chen · 2024 · Molecular Cancer
- Nicotinamide (niacin) supplement increases lipid metabolism and ROS‐induced energy disruption in triple‐negative breast cancer: potential for drug repositioning as an anti‐tumor agentMinsun Jung, Kyung‐Min Lee, Yebin Im, Seung Hyeok Seok, Hyewon Chung, Da-Young Kim, Dohyun Han, Cheng Hyun Lee, Eun Hye Hwang, Soo Young Park et al. · 2022 · Molecular Oncology
- Real‐Time NMR Spectroscopy for Studying MetabolismIslam Alshamleh, Nina M. Krause, Christian Paolo Richter, Nina Kurrle, Hubert L. Serve, Ulrich L. Günther, Harald Schwalbe · 2019 · Angewandte Chemie International Edition
- Lactate Dehydrogenase Inhibition With Oxamate Exerts Bone Anabolic EffectAlex M. Hollenberg, Charles Owen Smith, Laura C. Shum, Hani A. Awad, Roman A. Eliseev · 2020 · Journal of Bone and Mineral Research
- Genetically Encoded ATP Biosensors for Direct Monitoring of Cellular ATP DynamicsDonnell White, Qinglin Yang · 2022 · Cells
- Carrier Free O2‐Economizer for Photodynamic Therapy Against Hypoxic Tumor by Inhibiting Cell RespirationJiaqi Huang, Linping Zhao, Xiang Zhou, Lingshan Liu, Rongrong Zheng, Fu‐An Deng, Yibin Liu, Xiyong Yu, Shiying Li, Hong Bo Cheng · 2022 · Small
- Genetically Programmable Vesicles for Enhancing CAR‐T Therapy against Solid TumorsXianjun Li, Tianchuan Zhu, Ronghao Wang, Jian Chen, Lantian Tang, Wenwen Huo, Xi Huang, Qingdong Cao · 2023 · Advanced Materials
- Natural quinazolinones: From a treasure house to promising anticancer leadsHanbing Li, Gaohang Fu, Weihui Zhong · 2022 · European Journal of Medicinal Chemistry
- Targeting cancer-specific metabolic pathways for developing novel cancer therapeuticsSoumik Pal, Amit Kumar Sharma, Sam Padalumavunkal Mathew, Bithiah Grace Jaganathan · 2022 · Frontiers in Immunology
- Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52Wenliang Wang, Zongru Jiang, Chen Hu, Cheng Chen, Zhenquan Hu, Aoli Wang, Li Wang, Jing L. Liu, Wenchao Wang, Qingsong Liu · 2020 · Acta Pharmacologica Sinica
- Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesisZhaobing Ding, Russell Erick Ericksen, Qian Yi Lee, Weiping Han · 2021 · Amino Acids
- Circumventing the Crabtree effect: forcing oxidative phosphorylation (OXPHOS) via galactose medium increases sensitivity of HepG2 cells to the purine derivative kinetin ribosideMarta Orlicka-Płocka, Dorota Gurda, Agnieszka Fedoruk‐Wyszomirska, Eliza Wyszko · 2020 · APOPTOSIS
- Metabolic reprogramming in type 2 diabetes and the development of breast cancerSheree D. Martin, Sean L. McGee · 2018 · Journal of Endocrinology